Current Report Filing (8-k)
August 08 2019 - 5:46AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
__________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
August 8, 2019
CORINDUS
VASCULAR ROBOTICS, INC.
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
|
000-37406
|
|
30-0687898
|
(State
or Other
Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
309
Waverley Oaks Road, Suite 105
Waltham,
MA 02452
|
(Address
of Principal Executive Offices) (Zip Code)
|
(508)
653-3335
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☒
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2
(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4
(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Trading
Symbol
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.0001 per share
|
CVRS
|
NYSE
American
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
2.02 – Results of Operations and Financial Condition.
On
August 8, 2019, Corindus Vascular Robotics, Inc., a Delaware corporation (the “
Company
”), issued a press
release announcing financial results for the second quarter ended June 30, 2019. A copy of the press release is furnished as
Exhibit
99.1
to this Current Report on Form 8-K and is incorporated herein by reference.
The
press release is being furnished pursuant to Item 2.02 and the information contained therein shall not be deemed “filed”
for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities under
that section. Furthermore, the information in
Exhibit 99.1
shall not be deemed to be incorporated by reference into the
filing of the Company under the Securities Act of 1933, as amended.
We
do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any
change in events, conditions, or circumstances on which any forward-looking statement is based.
Item
9.01 – Financial Statements and Exhibits
(d)
Exhibits
.
Exhibit No.
|
|
Description
|
99.1
|
|
Press
Release of Corindus Vascular Robotics, Inc. dated August 8, 2019 announcing financial results for the quarter ended
June 30, 2019.
|
|
|
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
CORINDUS VASCULAR ROBOTICS, INC.
|
|
(Registrant)
|
|
|
|
Date:
August 8, 2019
|
By:
|
/s/
David W. Long
|
|
Name:
|
David W. Long
|
|
Title:
|
Chief Financial Officer
|
Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Corindus Vascular Robotics Inc (American Stock Exchange): 0 recent articles
More Corindus Vascular Robotics, Inc. News Articles